Following MEMO1′s isolation from this phosphorylated residue, it quickly became apparent—utilizing breast carcinoma cell lines—that the cellular machinery required for cell migration, initiated by ERBB2 signaling, was defective when cells were depleted of MEMO1 [1]. The gene discussed is ERBB2; the disease is breast carcinoma.